Skip to main content

Search Results: keywords:"exceptions and waivers"

  • The bill, S. 3558, aims to prevent U.S. government agencies from entering into contracts or spending funds with certain biotechnology companies that are considered to pose national security risks. These companies, referred to as "biotechnology companies of concern," include...

    Simple Explanation

    The bill wants to stop the government from working with certain biotech companies that could be dangerous, but it also says there are some special cases where this rule can be bent if needed.